An Iranian cohort study on biochemical markers and lipid profile in NAFLD found that an increase in FBS, TC, LDL/HDL ratio, TC/HDL ratio, AST/ALT ratio, GGT, ALT, and AST (OR > 1), and a reduction in HDL (OR < 1) significantly increased the likelihood of developing NAFLD (p < 0.05) [50]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.